Getinge (GETI B.ST) Stock Price
Getinge Price
Revenue has compounded at 1.5% per year over the past 10 years to 34.97 B SEK. Earnings per share have grown at 3.7% per year over the last 10 years. Getinge's net margin stands at 6.5%, down from 11% several years earlier. Getinge currently offers a dividend yield of about 2.23%. The payout ratio is around 55% of earnings. The dividend has grown at 5.1% per year over the past 10 years.
Getinge stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of Getinge over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Getinge stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Getinge's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | Getinge Price |
|---|
Getinge Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
Getinge Income Statement, Balance Sheet, Cash Flow Statement
| REVENUE (B SEK) |
|---|
| REVENUE GROWTH (%) |
| GROSS MARGIN (%) |
| GROSS INCOME (B SEK) |
| NET INCOME (B SEK) |
| NET INCOME GROWTH (%) |
| DIVIDEND (SEK)DIV. (SEK) |
| DIVIDEND GROWTH (%)DIV. GROWTH (%) |
| SHARES (M) |
| DOCUMENTS |
| 2023 | 2024 | 2025 | 2026e | 2027e | 2028e | 2029e | 2030e |
|---|---|---|---|---|---|---|---|
| 31.83 | 34.76 | 34.97 | 35.8 | 37.48 | 39.41 | 43.41 | 43.3 |
| 12.49 | 9.21 | 0.6 | 2.38 | 4.69 | 5.14 | 10.17 | -0.26 |
| 45.54 | 47.33 | 47.63 | 46.52 | 44.43 | 42.26 | 38.36 | 38.46 |
| 14.5 | 16.45 | 16.65 | 16.65 | 16.65 | 16.65 | 16.65 | 16.65 |
| 2.41 | 1.64 | 2.26 | 3.36 | 3.8 | 4.11 | 4.39 | 5.74 |
| -3.17 | -32.09 | 37.85 | 48.72 | 13.07 | 8.19 | 6.77 | 30.8 |
| 4.25 | 4.4 | 4.6 | 4.75 | 8.71 | 8.89 | - | - |
| 6.25 | 3.53 | 4.55 | 3.26 | 83.37 | 2.07 | – | – |
| 272.37 | 272.37 | 272.37 | 272.37 | 272.37 | 272.37 | 272.37 | 272.37 |
| – | – | – | – | – | – | – | – |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales Getinge generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Getinge retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Getinge's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares Getinge has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Getinge's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
Getinge stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
Getinge Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
Getinge business model & stock analysis
Getinge SWOT Analysis
Strengths
1. Established market presence: Getinge AB is a well-known and reputable company within the medical technology industry.
2. Diverse product portfolio: The company offers a wide range of medical devices and equipment, catering to various healthcare needs.
3. Strong research and development capabilities: Getinge invests heavily in R&D, enabling them to continuously innovate and introduce new products.
Weaknesses
1. Dependence on key markets: Getinge relies heavily on certain regions for its revenue, making it vulnerable to economic fluctuations in those markets.
2. High production costs: The company's manufacturing processes can be expensive, affecting its profit margins.
3. Limited presence in emerging markets: Getinge has relatively lower market penetration in developing countries compared to its competitors.
Opportunities
1. Increasing healthcare expenditure: As global healthcare spending continues to rise, Getinge can benefit from increased demand for medical devices and equipment.
2. Growing aging population: The aging population across the world presents an opportunity for Getinge to provide specialized healthcare solutions.
3. Expansion into emerging markets: The company can focus on expanding its presence in developing countries where there is a growing demand for healthcare solutions.
Threats
1. Intense competition: Getinge operates in a highly competitive industry, facing competition from both established players and emerging startups.
2. Stringent regulatory environment: Compliance with stringent regulations can pose challenges for Getinge in terms of product development and market approvals.
3. Technological advancements: Rapid technological advancements may make existing products obsolete, requiring continuous investment in innovation.
Getinge Eulerpool Fair Value
Getinge historical P/E ratio, EBIT multiple, and P/S ratio
Getinge annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
Getinge shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
Getinge Dividend History
33 years of dividend payments · 6 consecutive increases
Getinge dividend history and estimates
3 Years
5 Years
10 Years
25 Years
Max
Details
Getinge dividend payout ratio
3 Years
5 Years
10 Years
25 Years
Max
Details
Getinge Earnings Estimates
| Date | EPS estimate | Revenue Estimate | Quarterly report |
|---|---|---|---|
| 4/24/2024 | 2SEK | 7.86 BSEK | 2024 Q1 |
| 2/6/2024 | 3.46SEK | 9.17 BSEK | 2023 Q4 |
| 7/17/2023 | 2.72SEK | 7.35 BSEK | 2023 Q2 |
| 4/24/2023 | 2.05SEK | 6.92 BSEK | 2023 Q1 |
| 2/1/2023 | 4.34SEK | 8.98 BSEK | 2022 Q4 |
| 10/19/2022 | 2.51SEK | 6.96 BSEK | 2022 Q3 |
| 7/19/2022 | 2.16SEK | 6.87 BSEK | 2022 Q2 |
| 4/26/2022 | 2.39SEK | 6.47 BSEK | 2022 Q1 |
| 1/28/2022 | 3.61SEK | 8.2 BSEK | 2021 Q4 |
| 10/20/2021 | 2.54SEK | 6.72 BSEK | 2021 Q3 |
EESG©
Eulerpool ESG Scorecard© for the Getinge stock
EEnvironment
20
Environment
SSocial
20
Social
GGovernance (Corporate Governance)
4
Governance (Corporate Governance)
The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.
Getinge shareholder structure
| % | Name |
|---|---|
13.33956% | |
7.56595% | |
5.19185% | |
5.02841% | |
4.35279% | |
3.18666% |
Getinge Executives and Management Board
Mr. Mattias Perjos
(53)President, Chief Executive Officer, Director · since 2017
Mr. Johan Malmquist
(64)Independent Chairman of the Board · since 1997
Mr. Dan Frohm
(44)Director
Mr. Johan Bygge
(69)Independent Director
Ms. Cecilia Wennborg
(62)Independent Director
Frequently asked questions about Getinge
Getinge AB is a global medical technology company that specializes in providing solutions for hospitals and healthcare organizations. The business model of Getinge AB revolves around offering innovative products, systems, and services within areas such as surgical workflows, patient care, and infection control. They strive to improve patient outcomes and enable healthcare professionals to deliver efficient and safe care. With a focus on providing high-quality medical equipment and integrated solutions, Getinge AB aims to enhance the overall healthcare experience.
Getinge stock
Getinge Peer Group
Getinge Ticker
Getinge FIGI
All fundamentals and in-depth analysis of Getinge
Our stock analysis for Getinge Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Getinge Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.